Drug Repositioning: Approaches and Applications for Neurotherapeutics reviews history and advances in drug repositioning, with a special focus on therapeutics for nervous system diseases.
Drug Repositioning: Approaches and Applications for Neurotherapeutics reviews history and advances in drug repositioning, with a special focus on therapeutics for nervous system diseases.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Dr. Joel Dudley is associate professor of genetics and genomic sciences and director of biomedical informatics at Mount Sinai School of Medicine, New York (NY, USA). Dr. Laura Berliocchi is associate professor of pharmacology at the Department of Health Sciences, Magna Graecia University (Catanzaro, Italy).
Inhaltsangabe
Section I The Rationale and Economics of Drug Repositioning Chapter 1 Scientific and Commercial Value of Drug Repurposing David Cavalla Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The Ideas, the Pipeline, the Successes, and the Disappointments Hermann Mucke Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing Bruce Bloom Section II Repositioning Approaches and Technologies: From Serendipity to Systematic and Rational Strategies Chapter 4 Systematic Drug Repositioning Spyros N. Deftereos, Aris Persidis, Andreas Persidis, Eftychia Lekka, Christos Andronis, and Vassilis Virvillis Chapter 5 Technical Tools for Computational Drug Repositioning Francesco Napolitano Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari, and Ralph A. Tripp Chapter 7 Phenotypic Screening Christine M. Macolino-Kane, John R. Ciallella, Christopher A. Lipinski, and Andrew G. Reaume Section III Drug Repositioning for Nervous System Diseases Chapter 8 A Case Study: Chlorpromazine Francisco López-Munoz, Cecilio Álamo, and Silvia E. García-Ramos Chapter 9 Drug Repurposing for Central Nervous System Disorders: A Pillar of New Drug Discovery Mondher Toumi, Aleksandra Caban, Anna Kapüniak, Szymon Jaros¿awski, and Cecile Rémuzat Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies Giulia Ambrosi, Silvia Cerri, and Fabio Blandini Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease Maria P. del Castillo-Frias and Andrew J. Doig
Section I The Rationale and Economics of Drug Repositioning Chapter 1 Scientific and Commercial Value of Drug Repurposing David Cavalla Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The Ideas, the Pipeline, the Successes, and the Disappointments Hermann Mucke Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing Bruce Bloom Section II Repositioning Approaches and Technologies: From Serendipity to Systematic and Rational Strategies Chapter 4 Systematic Drug Repositioning Spyros N. Deftereos, Aris Persidis, Andreas Persidis, Eftychia Lekka, Christos Andronis, and Vassilis Virvillis Chapter 5 Technical Tools for Computational Drug Repositioning Francesco Napolitano Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari, and Ralph A. Tripp Chapter 7 Phenotypic Screening Christine M. Macolino-Kane, John R. Ciallella, Christopher A. Lipinski, and Andrew G. Reaume Section III Drug Repositioning for Nervous System Diseases Chapter 8 A Case Study: Chlorpromazine Francisco López-Munoz, Cecilio Álamo, and Silvia E. García-Ramos Chapter 9 Drug Repurposing for Central Nervous System Disorders: A Pillar of New Drug Discovery Mondher Toumi, Aleksandra Caban, Anna Kapüniak, Szymon Jaros¿awski, and Cecile Rémuzat Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies Giulia Ambrosi, Silvia Cerri, and Fabio Blandini Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease Maria P. del Castillo-Frias and Andrew J. Doig
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826